Search
for
Sort by
Research 61–90 of 271
- Diet in dermatology: Revisited
- Effect of a nutritional supplement on hair loss in women
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Cetuximab-Associated Elongation of the Eyelashes
- Alopecia areata: A review
- Scalp Itch: A Systematic Review
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Topically Applied Minoxidil in Baldness
- Hair and scalp disorders in women of African descent: an overview
- Topical absorption and systemic toxicity
- Scientific Opinion on the safety of “coriander seed oil” as a Novel Food ingredient
- Anticonvulsant-Induced Cutaneous Reactions
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Aqueous extract of Asiasari radix inhibits formalin-induced hyperalgesia via NMDA receptors
- Common Allergens Identified Based on Patch Test Results in Patients with Suspected Contact Dermatitis of the Scalp
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Inhibition of Established Tuberculin Hypersensitivity by Methptrexate,
- Oral medications for central serous chorioretinopathy: a literature review
- Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice
- Psychoactive drugs and skin
- Distinct Conditions Support a Novel Classification for Bradykinin-Mediated Angio-Oedema
- Drug eruptions in dermatology
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Promotion effect of Schisandra nigra on the growth of hair
- Focal and Generalized Alopecia
- Complications of Hair Transplant Procedures—Causes and Management
- Granulomatous pigmented purpuric dermatosis containing Propionibacterium acnes
- Nuclear factor (erythroid-derived 2)-like-2 pathway modulates substance P–induced human mast cell activation and degranulation in the hair follicle
- COVID‐19, androgens, and androgenic alopecia
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma